Immune-checkpoint inhibitors: immunophenotyping and clinical outcome to predict response at Barretos Cancer Hospital

• Grant number: 21/04100-6
• Support Opportunities: Scholarships in Brazil - Young Researchers
• Start date: May 01, 2021
• End date: April 30, 2025
• Field of knowledge: Health Sciences - Medicine - Surgery
• Principal Investigator: Lidia Maria Rebolho Batista Arantes
• Grantee: Lidia Maria Rebolho Batista Arantes
• Host Institution: Hospital do Câncer de Barretos. Fundação Pio XII (FP). Barretos , SP, Brazil
• Associated research grant: 19/07111-9 - Immune-checkpoint inhibitors: immunophenotyping and clinical outcome to predict response at Barretos Cancer Hospital, AP.JP

Scientific publications

(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)

SORROCHE, BRUNA PEREIRA; TEIXEIRA, RENAN DE JESUS; PEREIRA, CAIO AUGUSTO DANTAS; SANTANA, IARA VIANA VIDIGAL; VUJANOVIC, LAZAR; VAZQUEZ, VINICIUS DE LIMA; ARANTES, LIDIA MARIA REBOLHO BATISTA. PD-L1 Tumor Expression as a Predictive Biomarker of Immune Checkpoint Inhibitors' Response and Survival in Advanced Melanoma Patients in Brazil. DIAGNOSTICS, v. 13, n. 6, p. 11-pg., 2023-03-01. (19/03570-9, 21/04100-6, 19/07111-9, 21/10922-9)

TOSTES, KATIANE; SIQUEIRA, ALEXIA POLO; REIS, RUI MANUEL; LEAL, LETICIA FERRO; ARANTES, LIDIA MARIA REBOLHO BATISTA. Biomarkers for Immune Checkpoint Inhibitor Response in NSCLC: Current Developments and Applicability. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, v. 24, n. 15, p. 18-pg., 2023-08-01. (21/08352-0, 21/04100-6, 19/07111-9)